4.6 Review

Haemolytic uraemic syndrome associated with pancreatids: report of four cases and review of the literature

期刊

CLINICAL KIDNEY JOURNAL
卷 14, 期 8, 页码 1946-1952

出版社

OXFORD UNIV PRESS
DOI: 10.1093/ckj/sfaa245

关键词

acute kidney injury; complement; eculizumab; haemolytic uraemic syndrome; pancreatitis

资金

  1. ISCIII [PI 16/01685/FEDER]

向作者/读者索取更多资源

This study identified four cases of HUS following acute pancreatitis, with a mean age of 30 years and all patients being male, primarily due to excessive alcohol consumption. All patients developed progressive AKI shortly after pancreatitis onset, requiring kidney replacement therapy, but eventually showed good recovery. One patient treated with eculizumab had a faster recovery compared to others.
Background. The incidence of acute kidney injury (AKI) in patients with acute pancreatitis ranges from 15% to 40% and is associated with poor prognosis. Haemolytic uraemic syndrome (HUS) in the setting of acute pancreatitis is an uncommon association with fewer than 30 cases reported in the literature. Methods. A retrospective review of the clinical records at our institution between January 1981 and December 2019 was carried out to identify patients with acute pancreatitis and HUS. Additionally, a literature review was conducted on this topic. The aims of the study were to describe the clinical course and outcomes of patients affected by this condition. Results. Four cases of HUS following an acute pancreatitis were identified. The mean (+/- SD) age of the study group was 30 +/- 6 years, all of which were males. Excessive alcohol consumption was the main cause of acute pancreatitis in all four patients. HUS with progressive AKI developed in a median interval of 2 days from the onset of pancreatitis (range 1-3 days). All patients required kidney replacement therapy during the course of follow-up. A kidney biopsy was performed in two patients, showing typical thrombotic microangiopathic features. One case was treated with eculizumab, whereas the rest were treated with supportive care and/or plasma exchange. A normalization of haematological parameters and complete recovery of kidney function were observed in all patients at last follow-up, although this improvement was significantly faster in the patient treated with eculizumab. Conclusions. HUS may infrequently develop in patients with acute pancreatitis. An early identification of this complication is mandatory, and complement blockade with eculizumab may be associated with a faster kidney function recovery.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据